SCHEMBL21696313

SCHEMBL21696313

CS(=O)(=O)N1CCC(CI)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
ALDH1A1 P00352 5/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.39
FABP6 P51161 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5517671 0.84 TP53 (0.46) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL9921218 0.80 TP53 (0.50) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL1273104 0.78 TP53 (0.48) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL964176 0.78 NCF1 (0.52) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL560804 0.78 TP53 (0.48) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL24767352 0.78 TP53 (0.44) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL7887921 0.78 TP53 (0.44) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL24827061 0.78 TP53 (0.48) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL1964281 0.78 TP53 (0.44) TP53ALDH1A1ATML3MBTL1NPSR1
SCHEMBL772164 0.78 TP53 (0.44) TP53ALDH1A1ATML3MBTL1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2800745-B1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORY, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2020-02-12 EP disclosed